Intuitive Surgical, Inc. (ISRG) Position Increased by First Long Island Investors LLC

First Long Island Investors LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 162.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,700 shares of the medical equipment provider’s stock after purchasing an additional 9,100 shares during the period. First Long Island Investors LLC’s holdings in Intuitive Surgical were worth $5,365,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in ISRG. Lincoln National Corp acquired a new stake in shares of Intuitive Surgical during the third quarter worth $200,000. MUFG Americas Holdings Corp acquired a new stake in Intuitive Surgical in the third quarter valued at $208,000. Advisors Capital Management LLC acquired a new stake in Intuitive Surgical in the third quarter valued at $209,000. Capital Investment Counsel Inc acquired a new stake in Intuitive Surgical in the third quarter valued at $209,000. Finally, Coldstream Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the third quarter valued at $214,000. Institutional investors own 36.79% of the company’s stock.

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) traded down $2.58 on Friday, reaching $415.98. The company had a trading volume of 452,637 shares, compared to its average volume of 994,701. The company has a market cap of $46,710.00, a P/E ratio of 73.24, a P/E/G ratio of 4.90 and a beta of 0.50. Intuitive Surgical, Inc. has a 52-week low of $239.21 and a 52-week high of $452.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.27 by $0.27. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. The company had revenue of $892.40 million during the quarter, compared to analyst estimates of $866.54 million. During the same quarter in the previous year, the firm posted $2.03 EPS. The firm’s quarterly revenue was up 17.9% on a year-over-year basis. research analysts anticipate that Intuitive Surgical, Inc. will post 7.93 EPS for the current fiscal year.

In other news, EVP Curet Myriam sold 262 shares of the business’s stock in a transaction on Tuesday, January 30th. The stock was sold at an average price of $431.50, for a total transaction of $113,053.00. Following the sale, the executive vice president now directly owns 2,152 shares of the company’s stock, valued at $928,588. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Jamie Samath sold 959 shares of the company’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $398.46, for a total value of $382,123.14. Following the transaction, the vice president now directly owns 536 shares in the company, valued at $213,574.56. The disclosure for this sale can be found here. In the last 90 days, insiders sold 85,016 shares of company stock valued at $35,133,026. Insiders own 2.20% of the company’s stock.

ISRG has been the subject of a number of research analyst reports. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 price target for the company in a research report on Tuesday, December 12th. ValuEngine cut Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Friday, December 29th. Goldman Sachs Group reiterated a “buy” rating on shares of Intuitive Surgical in a research report on Saturday, November 18th. BidaskClub lowered Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 12th. Finally, Morgan Stanley raised their price target on Intuitive Surgical from $450.00 to $500.00 and gave the stock an “overweight” rating in a research note on Friday, January 26th. One research analyst has rated the stock with a sell rating, six have given a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. Intuitive Surgical presently has an average rating of “Buy” and a consensus target price of $408.48.

ILLEGAL ACTIVITY NOTICE: This report was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/18/first-long-island-investors-llc-grows-holdings-in-intuitive-surgical-inc-isrg.html.

Intuitive Surgical Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply